BACKGROUND Immune check-point inhibitors-induced colitis(ICPIs-induced colitis) is one of the immune-related side effects.Steroids and Infliximab are commonly used to treat it.The patients of our report were treated b...BACKGROUND Immune check-point inhibitors-induced colitis(ICPIs-induced colitis) is one of the immune-related side effects.Steroids and Infliximab are commonly used to treat it.The patients of our report were treated by Vedolizumab.CASE SUMMARY The two patients went to the doctor with bloody stools and were treated by Sintilimab and Camrelizumab,respectively,for their malignant tumors.They were diagnosed as ICPIs-induced colitis based on endoscopic and histologic examination.The original immunotherapy was ceased while the anti-inflammatory therapy was introduced.The patients’ colitis symptoms disappeared after the treatment and no recurrence was found during the follow-up period.The unique feature about the case reports is that Vedolizumab combined with short-term corticosteroids had achieved good therapeutic effects.CONCLUSION For the symptoms of bloody diarrhea after the ICPIs treatment of cancer,the possibility of ICPIs-induced colitis should be considered.Vedolizumab combined with short-term corticosteroids may be appropriate for the treatment.展开更多
文摘BACKGROUND Immune check-point inhibitors-induced colitis(ICPIs-induced colitis) is one of the immune-related side effects.Steroids and Infliximab are commonly used to treat it.The patients of our report were treated by Vedolizumab.CASE SUMMARY The two patients went to the doctor with bloody stools and were treated by Sintilimab and Camrelizumab,respectively,for their malignant tumors.They were diagnosed as ICPIs-induced colitis based on endoscopic and histologic examination.The original immunotherapy was ceased while the anti-inflammatory therapy was introduced.The patients’ colitis symptoms disappeared after the treatment and no recurrence was found during the follow-up period.The unique feature about the case reports is that Vedolizumab combined with short-term corticosteroids had achieved good therapeutic effects.CONCLUSION For the symptoms of bloody diarrhea after the ICPIs treatment of cancer,the possibility of ICPIs-induced colitis should be considered.Vedolizumab combined with short-term corticosteroids may be appropriate for the treatment.
